Elevated Autoimmune Disorder Prevalence in Women with Primary Ovarian Insufficiency
Overview
This population-based study found that 25% of women diagnosed with primary ovarian insufficiency (POI) have at least one autoimmune disease, with significantly increased risks for several specific autoimmune conditions. However, no increased autoimmune risk was observed in their family members, suggesting environmental or hormonal factors may influence disease expression.
Background
Primary ovarian insufficiency (POI) is characterized by amenorrhea before age 40, elevated follicle-stimulating hormone, and low estradiol levels. Autoimmune mechanisms contribute to a subset of POI cases, particularly involving autoimmune polyglandular syndromes and thyroid disease. Autoimmune diseases often manifest during reproductive years and have a known genetic predisposition, raising questions about familial clustering in POI. Understanding the relationship between POI and autoimmune disorders can guide clinical evaluation and management.
Data Highlights
Autoimmune Disease
Odds Ratio (95% CI)
P Value
Autoimmune Hypothyroidism
6.88 (5.71, 8.22)
<.001
Adrenal Insufficiency
4.72 (1.73, 10.28)
0.0020
Type 1 Diabetes
4.13 (2.14, 7.22)
5.25×10⁻⁵
Rheumatoid Arthritis
5.66 (3.10, 9.50)
3.70×10⁻⁷
Vitiligo
15.33 (6.16, 31.58)
5.25×10⁻⁷
Celiac Disease
7.58 (3.47, 14.39)
4.47×10⁻⁶
Psoriasis
3.90 (2.01, 6.81)
9.04×10⁻⁵
Systemic Lupus Erythematosus
4.43 (1.63, 9.64)
0.0027
Key Findings
25% of women with POI had at least one autoimmune disease diagnosis.
Women with POI showed significantly increased risks for autoimmune hypothyroidism, adrenal insufficiency, type 1 diabetes, rheumatoid arthritis, vitiligo, celiac disease, psoriasis, and systemic lupus erythematosus compared to population rates.
The highest relative risk was observed for vitiligo (OR 15.33) and celiac disease (OR 7.58).
No increased risk of autoimmune diseases was found in first-, second-, or third-degree relatives of women with POI.
The autoimmune risk in POI is largely related to autoimmune polyglandular syndromes and autoimmune hypothyroidism.
The lack of familial clustering suggests environmental or hormonal influences may modulate autoimmune disease expression in POI.
Clinical Implications
Clinicians should be vigilant for autoimmune disorders in women diagnosed with POI, particularly thyroid disease and polyglandular autoimmune syndromes, to enable timely diagnosis and management. Family members of women with POI do not appear to have increased autoimmune risk, indicating that screening strategies may be focused on affected individuals rather than relatives. Understanding the autoimmune associations may guide personalized care and counseling.
Conclusion
This study confirms a markedly increased prevalence of autoimmune diseases in women with POI but not in their relatives, highlighting the importance of autoimmune evaluation in POI patients and suggesting non-genetic factors contribute to disease manifestation.
References
Wheeler et al. 2024 -- The Prevalence of Autoimmune Disorders is Elevated in Women Diagnosed with Primary Ovarian Insufficiency
